Interleukin-6 (IL-6) Extended Panel | 1,400 AED | DNA Labs UAE

Executive Summary & Core Metrics

Clinical Sensitivity: 99.9% diagnostic accuracy via ISO 15189 accredited processing with CLIA/ECLIA technology at picogram-level detection.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across Dubai and major UAE cities.
Physician Guidance: Complimentary telephonic post-test consultation with a licensed general practitioner for result interpretation and clinical context.
Direct Billing: Insurance verification and direct billing support via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The Interleukin-6 (IL-6) Extended Panel provides high-sensitivity quantification of the pleiotropic cytokine IL-6 using automated chemiluminescent immunoassay (CLIA/ECLIA) technology aligned with IFCC reference standards. This assay delivers same-day results essential for evaluating systemic inflammatory states, monitoring cytokine release syndromes, guiding anti-aging biomarker profiling, and assessing chronic disease progression. IL-6 is a key mediator of the acute-phase response and serves as a critical marker in immunology, rheumatology, and critical care medicine.

Feature	DNA Labs UAE IL-6 Panel	Conventional Alternative
Detection Sensitivity	Ultra-sensitive (pg/mL range)	Standard ELISA (ng/mL range)
Methodology	CLIA / ECLIA – fully automated, IFCC-aligned	Manual ELISA – higher inter-assay variability
Turnaround Time	Same-day (sample collected before 4:00 PM)	2–3 working days
Regulatory Alignment	DHA-licensed, ISO 15189 accredited	Variable compliance standards

Physician Insight & Safety Protocols

“IL-6 is a powerful, pleiotropic cytokine that can rise acutely in infection, chronic inflammatory conditions, and even after vaccination. A single elevated value must never be interpreted in isolation; it requires correlation with hs-CRP, clinical presentation, and longitudinal monitoring. Patients should continue all prescribed medications unless explicitly advised otherwise by their treating physician.”

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Advisory & Clinical Guidance

Medication Safety: Do not discontinue or modify prescribed immunosuppressants, biologics, or anti-inflammatory medications without consulting your doctor prior to testing.
Biotin Interference: Patients taking biotin supplements at or above 5 mg per day should discontinue at least 8 hours before blood draw to avoid falsely suppressed or elevated results.
Informed Consent: All patients or their legal guardians must provide written informed consent before sample collection, as mandated by Federal Decree-Law No. 4 of 2016 on Medical Liability.

Exclusion Criteria & Emergency Indicators

Pre-Test Exclusion: Active febrile illness or systemic infection within the past 48 hours, recent vaccination within 14 days, or inability to provide consent for minors without a legal guardian.
Emergency Red Flags: If you experience sudden severe chest pain, difficulty breathing, confusion, hypotension, or signs suggestive of septic shock, seek immediate emergency medical care — do not wait for laboratory results.

Patient FAQ & Clinical Guidance

1. What does the Interleukin-6 Extended Panel detect?

Answer: This test precisely measures the concentration of interleukin-6 in serum or plasma. IL-6 is a key cytokine that reflects systemic inflammation, cytokine storm risk, chronic disease activity, and age-related inflammatory processes known as inflammaging.

2. Why is the sample collection protocol so detailed?

Answer: Strict pre-analytical conditions — including fasting for 8–10 hours, avoidance of biotin, immediate centrifugation at 4°C, and temperature-controlled cold-chain transport — are required to eliminate pre-analytical variability and ensure accurate, reproducible IL-6 results.

3. Can this test help monitor anti-aging or longevity therapies?

Answer: Yes. IL-6 is a validated biomarker of inflammaging — the chronic low-grade inflammation associated with biological aging. Serial monitoring of IL-6 levels assists clinicians in evaluating treatment response to anti-inflammatory interventions and managing biological age trajectories.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare information security regulations. Patient data collected during the IL-6 testing process is handled under the following legal frameworks:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the collection, processing, storage, and transfer of personal health data with explicit patient consent and data minimization principles.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — mandating secure electronic health record systems, audit trails, and breach notification protocols for all digital health data.
Federal Decree-Law No. 4 of 2016 on Medical Liability — ensuring informed consent, clinical accountability, and patient safety standards across all diagnostic procedures.

All test results are delivered through encrypted channels. Patients retain the right to access, rectify, or request deletion of their data in accordance with PDPL Article 7. For privacy-related inquiries, contact our Data Protection Officer at dpo@dnalabs.ae.

Clinical & Logistical Metadata

Test Name	Interleukin-6 (IL-6) Extended Panel
Price (AED)	1,400
Turnaround Time	Same-day (sample collected before 4:00 PM)
Sample Type / Matrix	Serum or Plasma (Peripheral Blood)
Methodology Used	CLIA / ECLIA (Chemiluminescent Immunoassay, IFCC-aligned)
ICD-10-CM Code	R79.89
LOINC Code	35358-7
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE